ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
May 10, 2021Alebund Pharmaceuticals today announced that it has raised $60 million in its Series B financing round which was led by Quan Capital, and followed by a prominent sovereign wealth fund, 3E Bioventures Capital, and Sherpa Healthcare Partners. -
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
March 22, 2021Innoforce Pharmaceuticals, a biopharmaceutical innovation and partnership company, announced today the completion of a 625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020.
Pharma Sources Insight January 2025
